The promise of remote patient monitoring is showing itself in more and more telemedicine use cases, with huge potential for day-to-day wellness, management of chronic conditions and the promotion of health equity.

Oren Nissim is CEO and cofounder of Brook Health, a care management company that uses telehealth and artificial intelligence for home-based care. He sees big things for RPM in 2025, helping across a variety of important areas for patients where they live. We spoke with him about the trends he sees shaping up for the year ahead.

Q. You predict big things for congestive heart failure and remote patient monitoring this year. What do you see happening?

A. 2025 will transform congestive heart failure management as healthcare organizations recognize that traditional episodic care models can't effectively manage the growing CHF population. Remote patient monitoring will mature beyond simple vital sign tracking to become an intelligent early warning system that combines real-time physiological data with AI-driven pattern recognition to detect subtle signs of deterioration days before serious symptoms emerge.

The integration of AI-powered monitoring with human care teams will enable a new standard of proactive CHF management. Healthcare organizations will implement sophisticated triage protocols that automatically escalate concerning patterns to clinical teams, while providing patients with personalized guidance for day-to-day self-management.

This combination will dramatically reduce the burden on emergency departments while improving patient outcomes.

The most significant impact will come from the ability to deliver specialized CHF expertise into every patient's home. Remote patient monitoring platforms will enable cardiologists to extend their reach beyond geographic boundaries, providing expert guidance to local care teams and ensuring every CHF patient has access to specialist-level care regardless of location.

Q. Another area of RPM you say will see significant activity is work with GLP-1 drugs, the medications prescribed for controlling diabetes and losing weight. How are these two aspects of care going to blend?

A. 2025 will mark a critical intersection between the GLP-1 revolution and remote patient monitoring as healthcare organizations grapple with supporting unprecedented numbers of patients on these transformative medications.

The combination of GLP-1s' powerful effects on multiple chronic conditions with continuous remote monitoring will create opportunities for more precise medication management and earlier intervention when problems arise.

Healthcare organizations will develop sophisticated remote patient monitoring protocols specifically designed for patients on GLP-1s, tracking not just weight and vital signs but also medication adherence, side effects, and impacts across multiple conditions including diabetes, heart failure and obesity.

This comprehensive monitoring will enable care teams to optimize dosing, manage side effects and ensure patients achieve maximum benefit from these expensive medications.

The integration of remote patient monitoring with GLP-1 therapy will generate unprecedented insights into these medications' real-world impacts on chronic disease progression. This data will enable healthcare organizations to identify which patients are most likely to benefit from GLP-1s, predict potential complications and develop more effective protocols for managing multiple chronic conditions simultaneously.

Q. Health equity is a big, big topic in healthcare today. Where do you see progress this year?

A. 2025 will reveal remote care's greater potential to address long standing healthcare inequities by bringing high-quality chronic disease management into underserved communities. Healthcare organizations will develop culturally competent remote care programs that combine RPM technology with human support to overcome barriers of language, health literacy and trust that have historically limited telehealth adoption in vulnerable populations.

The most successful programs will extend beyond traditional clinical monitoring to address social determinants of health, integrating community health workers into remote care teams, and connecting patients with local resources for nutrition, transportation and social support.

This comprehensive approach will demonstrate that technology, when properly combined with human touch, can bridge historical gaps in care access and quality.

The impact on health equity will be particularly evident in rural and urban underserved areas, where remote care will enable local primary care providers to manage complex chronic conditions with specialist-level support. By bringing expert guidance and continuous monitoring to communities that have historically lacked access to specialty care, these programs will begin to close longstanding disparities in chronic disease outcomes.

Follow Bill's HIT coverage on LinkedIn: Bill Siwicki
Email him: bsiwicki@himss.org
Healthcare IT News is a HIMSS Media publication